ANZUP - Non-clear Cell Post Immunotherapy CABozantinib (UNICAB)

Clinical trial NCT03685448 · COMPLETED

Trial details

NCT number: NCT03685448
Sponsor: Australian and New Zealand Urogenital and Prostate Cancer Trials Group
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Renal Cell Carcinoma Papillary Renal Cell Carcinoma Type 1 Papillary Renal Cell Carcinoma Type 2 Chromophobe Renal Cell Carcinoma Sarcomatoid Renal Cell Carcinoma Xp11.2 Translocation-Related Renal Cell Carcinoma

Start date: 2019-04-11
Primary completion: 2024-12-30
Enrollment: 35

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.